1 0 3 5 a r t i c l e s Cilia protrude from eukaryotic cells and serve as signaling hubs regulating important cellular processes such as sensory reception and developmental signaling 1,2 . To construct a cilium, the cell uses ciliary trafficking pathways that rely on molecular motors 3 , intraflagellar transport (IFT) and BBSome complexes for cargo recognition [4] [5] [6] [7] . Whereas IFT complexes appear to transport mainly precursors of the ciliary axoneme 8-10 , the BBSome is involved in the transport of ciliary membrane proteins such as G protein-coupled receptors and components of the hedgehog signaling pathway [11] [12] [13] [14] [15] . The BBSome consists of eight BBS protein subunits 13, 16 in which genetic mutations result in BBS, a ciliopathic human genetic disorder characterized by obesity, blindness, mental retardation and kidney failure [17] [18] [19] [20] . The BBSome travels between the base and tip of cilia in association with IFT complexes [21] [22] [23] and also mediates the ciliary export of several proteins [11] [12] [13] [14] [15] 24, 25 . Interestingly, mutations in the IFT-complex subunits IFT172 and IFT27 were recently shown to also cause BBS 26, 27 . The small GTPase IFT27 is of particular interest because it was shown to be required for cilium-mediated hedgehog signaling and the ciliary export of the BBSome [28] [29] [30] . To fulfill its function in membraneprotein trafficking, the BBSome is recruited to membranes as the major effector of the small GTPase ARL6 (also known as BBS3) in the active GTP-bound form, and this recruitment is necessary for ciliary entrance of BBSomes 13, 16, 31 . Currently, little is known about the mechanism of BBSome recruitment to membranes by ARL6-GTP or the molecular basis for the disease phenotypes of BBS mutations.
a r t i c l e s
Cilia protrude from eukaryotic cells and serve as signaling hubs regulating important cellular processes such as sensory reception and developmental signaling 1, 2 . To construct a cilium, the cell uses ciliary trafficking pathways that rely on molecular motors 3 , intraflagellar transport (IFT) and BBSome complexes for cargo recognition [4] [5] [6] [7] . Whereas IFT complexes appear to transport mainly precursors of the ciliary axoneme [8] [9] [10] , the BBSome is involved in the transport of ciliary membrane proteins such as G protein-coupled receptors and components of the hedgehog signaling pathway [11] [12] [13] [14] [15] . The BBSome consists of eight BBS protein subunits 13, 16 in which genetic mutations result in BBS, a ciliopathic human genetic disorder characterized by obesity, blindness, mental retardation and kidney failure [17] [18] [19] [20] . The BBSome travels between the base and tip of cilia in association with IFT complexes [21] [22] [23] and also mediates the ciliary export of several proteins [11] [12] [13] [14] [15] 24, 25 . Interestingly, mutations in the IFT-complex subunits IFT172 and IFT27 were recently shown to also cause BBS 26, 27 . The small GTPase IFT27 is of particular interest because it was shown to be required for cilium-mediated hedgehog signaling and the ciliary export of the BBSome [28] [29] [30] . To fulfill its function in membraneprotein trafficking, the BBSome is recruited to membranes as the major effector of the small GTPase ARL6 (also known as BBS3) in the active GTP-bound form, and this recruitment is necessary for ciliary entrance of BBSomes 13, 16, 31 . Currently, little is known about the mechanism of BBSome recruitment to membranes by ARL6-GTP or the molecular basis for the disease phenotypes of BBS mutations.
We set out to gain mechanistic insights into the membrane recruitment of the BBSome by ARL6. It was previously shown that ARL6-GTP binds the BBSome and that the interaction is likely to be mediated by the BBS1 subunit 31 . We purified a stable complex of ARL6-GTP bound to the N-terminal domain of BBS1 and determined the crystal structure of this complex as well as that of ARL6 alone bound to either GDP or GTP. These results provide a molecular basis for recruitment of BBSome effectors by ARL6-GTP. We probed the interaction interface between ARL6-GTP and BBS1 and showed that single point mutations disrupted complex formation and prevented the recruitment of the BBSome into cilia in a cell-based system. Finally, we tested the impact of two disease-associated BBS1 mutations to demonstrate that the very frequently occurring BBS1 M390R mutant fails to interact with ARL6-GTP, providing a molecular rationale for patient pathologies.
RESULTS

ARL6DN-GTP binds BBS1N with ~0.5-mM affinity
To unravel the molecular basis for membrane recruitment of the BBSome and BBS disease phenotypes, we purified Homo sapiens (Hs) and C. reinhardtii (Cr) versions of ARL6 (full length or ∆N (residues 1-15 deleted)) in the GDP-or GTP-bound form; the N-terminal domain of BBS1 (HsBBS1N (residues 1-416) and CrBBS1N (residues 1-425)); and the ARL6∆N-GTP-BBS1N complex ( Fig. 1a and Supplementary Fig. 1 ). Both Chlamydomonas and human ARL6∆N-GTP-BBS1N complexes were stable during size-exclusion chromatography (SEC) and eluted in peaks well separated from the peaks of excess ARL6-GTP ( Fig. 1a and Supplementary Fig. 1a) . To determine the affinity between the two proteins, we carried out isothermal titration calorimetry (ITC) measurements. The results demonstrated that CrBBS1N binds CrARL6∆N-GTP to form a stoichiometric complex with a K d of 0.35 µM (Fig. 1b) . Consistently with this, HsBBS1N bound HsARL6∆N-GTP with a K d of 0.54 µM to form a stoichiometric complex (Supplementary Fig. 1a ). Given that ARL6 and BBS1 proteins are well conserved across species (40-50% 1 0 3 6 VOLUME 21 NUMBER 12 DECEMBER 2014 nature structural & molecular biology a r t i c l e s conservation between Chlamydomonas and human proteins), we tested whether CrBBS1N interacts with HsARL6∆N-GTP. Indeed, we found that HsARL6∆N-GTP-CrBBS1N could be purified by SEC and that the K d for this chimeric complex was 0.30 µM ( Supplementary  Fig. 1d ). We conclude that ARL6-GTP forms a stable complex with the N-terminal domain of BBS1 and that the interaction is conserved between the Chlamydomonas and human proteins.
Structures of CrARL6∆N-GTP and CrARL6∆N-GTP-CrBBS1N
We determined crystal structures of CrARL6∆N-GTP and the CrARL6∆N-GTP-CrBBS1N complex (Fig. 1c,d, Supplementary  Fig. 2a,b and Table 1 ). We determined the CrARL6∆N-GTP structure at 2.2-Å resolution by molecular replacement, using the available structure of HsARL6-GTP 32 . Crystals of the CrARL6∆N-GTP-CrBBS1N complex reproducibly diffracted to resolutions of 3.1-3.5 Å, and we determined the structure by using experimental phasing on a mercury derivative (Supplementary Fig. 2f ). The structures showed that CrARL6 adopts a classical small-GTPase fold and that CrBBS1N adopts the fold of a seven-bladed WD40-like β-propeller (Fig. 1c,d) . A comparison of the CrARL6∆N-GTP structure with previously published structures of human and Trypanosoma brucei ARL6-GTP 32, 33 revealed largely identical structures with r.m.s. deviations of 0.7-0.9 Å (Supplementary Fig. 2a) . The CrARL6∆N-GTP-CrBBS1N structure revealed an elongated assembly with complex formation mediated npg a r t i c l e s by blades 1 and 7 of the CrBBSN1 β-propeller and helix α3, switch 2 and the loop preceding helix α1 from the GTP-binding region of CrARL6 (Fig. 1c,d ). The finding that BBS1 binds at the switch regions of the GTP site of ARL6 is compatible with the BBSome being an effector for ARL6 (ref. 31 ). Comparison of ARL6∆N-GTP and ARL6∆N-GTP-BBS1N structures revealed that GTP-bound ARL6 is already in a conformation competent for BBS1 binding with no major structural changes occurring upon formation of the BBS1N complex ( Supplementary Fig. 2b ).
The structure of the CrARL6∆N-GTP-CrBBS1N complex revealed a highly complementary but relatively small interaction interface with only 600 Å 2 of buried surface area (Supplementary Fig. 2e ). The interaction interface is bipartite, with one hydrophilic patch closer to the GTP pocket and one hydrophobic patch farther away (Fig. 2a,b) . The hydrophobic patch is formed by L100, V103 and V104 from helix α3 of CrARL6 contacting L41, I415 and M417 from blade 1 and T86 from blade 2 of CrBBS1N (Fig. 2a,b) . The hydrophilic patch is made by D26 and N27 from the loop preceding helix α1, R77 from switch 2 and R101 and E108 from helix α3 of CrArl6 that interact with R399, E400 and R420 from blade 1 of the CrBBS1N β-propeller (Fig. 2a,b) . The ARL6-BBS1N interface is highly conserved between different species ( Fig. 2a and Supplementary Fig. 3 ). Of the eight residues from ARL6 directly involved in BBS1N binding, all are completely conserved between the Chlamydomonas and human proteins ( Supplementary Fig. 3 ). Of the seven BBS1N residues that interact with ARL6, five are completely conserved between Chlamydomonas and human protein sequences, whereas one residue represents a conservative hydrophobic substitution (M417 in CrBBS1 and I401 in HsBBS1), and one residue constitutes a threonine-to-proline substitution (T86 in CrBBS1 and P74 in HsBBS1) (Supplementary Fig. 3 ). 
npg a r t i c l e s
These data support the notion of an evolutionarily conserved ARL6-BBS1 complex.
Mutation analysis of human ARL6∆N-BBS1N
We designed, on the basis of the structure of CrARL6∆N-GTP-CrBBS1N described above, single point mutations of human ARL6 and BBS1N and tested them for their ability to form a protein complex. We introduced nonconservative substitutions in HsARL6 to replace residues in either the hydrophobic or the hydrophilic interaction interface and purified the recombinant glutathione S-transferase (GST)-tagged proteins. Then we incubated HsARL6 variants with native BBSome from bovine retinal extract and probed for interaction in pulldown experiments (Fig. 2c) . Whereas GST-tagged HsARL6 Q73L ∆N without mutations in the interface efficiently captured the BBSome from retinal extracts, R77A, L100E or E108A single-point-mutant ARL6 failed to do so (Fig. 2c) .
(All mutants used in this study were tested for proper folding by SEC and for nucleotide binding by NMR (as shown for ARL6 mutants in Supplementary Fig. 4 ).) Residues of the interaction interface between ARL6 and BBS1N elucidated from the CrARL6∆N-GTP-CrBBS1N structure are thus required for the efficient binding of the mammalian BBSome to ARL6. To reciprocally probe for interaction, we designed HsBBS1N point mutations (I399E or R404A) and performed pulldown experiments with GST-tagged HsARL6. The results (Fig. 2d) demonstrated that a single point mutation in either the hydrophilic (R404A) or the hydrophobic (I399E) interface is sufficient to abolish complex formation, consistently with the relatively small buried surface area within the CrARL6∆N-GTPCrBBS1N complex.
ARL6 E108A mutation prevents BBSome recruitment to cilia
Previously published data have shown that active GTP-bound ARL6 is required to recruit the BBSome to membranes and to allow access of the BBSome complex to the ciliary compartment 31 . Because we showed that single ARL6 point mutations were sufficient to abolish the interaction with native BBSome from retinal extracts, we hypothesized that the ciliary entry of BBSomes might also be compromised. To test the functional implications of the ARL6-GTP-BBS1 interaction in a cellular system, we thus generated clonal RPE-hTERT cell lines that expressed either wild-type 31 or E108A-mutant ARL6. After knocking down endogenous ARL6 by short interfering RNA (siRNA) targeting the 3′ untranslated region (UTR), we monitored the recruitment of the BBSome to cilia (Fig. 3) . The knockdown of Arl6 reduced the percentage of BBSome-positive cilia from above 40% to below 5%, and this effect could be fully rescued by reintroduction of wild-type ARL6. In contrast, rescue experiments with the ARL6 E108A interface mutant, which abolished BBSome interaction in pulldown experiments (Fig. 2c) , failed to increase the number of BBSome-positive cilia (Fig. 3) . These data confirmed the structural results and, given that the BBSome is the major effector of ARL6, suggested that the ARL6-GTP-BBS1 interaction is required to recruit the BBSome to cilia.
Structure of CrARL6∆N-GDP
CrARL6 recombinantly expressed in Escherichia coli copurified with GTP bound at the GTPase site (Supplementary Fig. 2h ). After treatment with EDTA, we replaced the GTP with GDP and determined the crystal structure of CrARL6∆N-GDP at 1.4-Å resolution by experimental phasing with a cadmium derivative (Fig. 4 and Supplementary Fig. 2i ). Small GTPases of the Arf family associate with membranes via an amphipathic N-terminal helix. The exchange from GDP-to GTP-bound Arf results in a shift of two amino acids in the interswitch region, which in turn pushes out and exposes the N-terminal amphipathic helix to allow membrane association 34, 35 . To examine whether ARL6 is likely to use a similar mechanism for membrane attachment, we superposed the structures of CrARL6∆N bound to either GDP or GTP with the equivalent structures of Arf1 (refs. 34, 35) , revealing similar interswitch conformations ( Supplementary Fig. 2c,d) . The structural studies of CrARL6 presented here were carried out in the absence of the amphipathic N-terminal helix. Nevertheless, our analysis demonstrated a shift of two residues in the interswitch region of ARL6-GTP compared to ARL6-GDP ( Fig. 4a and Supplementary Fig. 2c,d ). Because this shift is a hallmark of Arf proteins, the structures thus support a canonical Arf mechanism of membrane association via the amphipathic N-terminal helix of ARL6. Furthermore, in the structure of CrARL6∆N-GDP, both switch 1 and switch 2 adopted substantially altered conformations in comparison to the CrARL6∆N-GTP structure (Fig. 4a) . The reason that GTP-but not GDP-bound CrARL6 can recruit the BBSome to membranes 31 is probably a result of structural changes in switch 2. The conformational change in switch 2 upon hydrolysis of GTP to GDP results in the disruption of the ARL6 R77 -BBS1 E400 salt bridge and would cause ARL6 R77 to clash with BBS1N R420 (Fig. 4b) . These a r t i c l e s observations explain why GTP-bound but not GDP-bound ARL6 have been shown to recruit the BBSome to membranes [21] [22] [23] 31 .
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CrBBS1N is not a GTPase-activating protein for CrARL6
The crystal structures of CrARL6∆N-GTP and CrARL6∆N-GTPCrBBS1N presented here both have GTP bound at the GTPase site, as demonstrated by the well-defined electron densities ( Supplementary  Fig. 2g,h) . Because nucleotides were not added to the sample, we conclude that the GTP copurified with the proteins, a result suggesting that GTP hydrolysis by CrARL6∆N and CrARL6∆N-BBS1N is slow. We confirmed this notion with GTPase assays ( Supplementary  Fig. 5 ), and it is compatible with the fact that the catalytic glutamine found in most small GTPases (Q73 in HsARL6) is an alanine in CrARL6. In the CrARL6∆N-GTP-CrBBS1N structure, we found no residues from the CrBBS1N subunit inserted into the GTP-binding pocket of Arl6∆N, a result in agreement with the slow hydrolysis rate by the CrARL6∆N-GTP-CrBBS1N complex. We conclude that CrBBS1N does not act as a GTPase-activating protein (GAP) for CrArl6∆N, which is in contrast to COPII coat recruitment by Sar1, in which the COPII component Sec23 serves as a Sar1 GAP by introducing an arginine into the active site, thus promoting GTP hydrolysis 36 . Membrane recruitment of BBSomes by ARL6-GTP may thus be long lived in the absence of an external GAP.
BBS1 M390R mutant does not interact with ARL6-GTP
Mutational analyses of patients with BBS have uncovered several point mutations in BBS proteins including variants that disrupt GTP binding by ARL6 (refs. 32,37,38) . Interestingly, a single M390R point mutation in BBS1 represents ~80% of all BBS1 disease mutations and accounts for 18-32% of all BBS disease mutations 39, 40 . Supplementary Fig. 1 .) 
We modeled the human ARL6∆N-GTP-BBS1N structure on the basis of the CrARL6∆N-GTP-CrBBS1N structure reported here and mapped reported BBS1 disease mutations onto the structure (Fig. 5a) . This analysis revealed that HsBBS1 M390 is located at blade 1 of the β-propeller close to the GTP-binding site of ARL6 (Fig. 5a) . The HsBBS1 M390 residue is not directly involved in the interaction interface with ARL6, but its position suggests that mutation to arginine might disrupt the structure of the β-propeller in the region around blade 1 of BBS1 and thus indirectly prevent complex formation with ARL6. To test this notion, we purified the HsBBS1N M390R mutant protein for interaction studies (Supplementary Fig. 1c) . Although the HsBBS1N M390R purification resulted in a much lower yield than that for the wild-type protein, HsBBS1N M390R eluted in SEC as a broad peak well separated from the void volume in which aggregated proteins elute (Supplementary Fig. 1c) . To assess the folding state of the HsBBS1N M390 protein in more detail, we carried out CD experiments. The CD spectrum of HsBBS1N M390R was that of an overall folded protein, but it indicated substantially lower β-strand content compared to that of wild-type HsBBS1N, thus suggesting that the β-propeller of HsBBS1N M390R protein is partly unstructured (Fig. 5b) . The HsBBS1N M390R mutant protein failed to interact with GST-tagged HsARL6 Q73L and HsARL6 Q73L ∆N in pulldown experiments ( Fig. 5c and Supplementary Fig. 6 ). Additionally, ITC and SEC experiments did not detect any interaction between HsARL6 Q73L ∆N and HsBBS1N M390R ; this suggested that the affinity is at least two orders of magnitudes lower than that for wild-type BBS1N ( Fig. 5d and Supplementary Fig. 1c) . The main defect of the BBS1 M390R mutation in patients with BBS thus appears to be misfolding of the β-propeller, which in turn disrupts the association with binding partners such as ARL6. For a positive control, we used the BBS1N E234K mutant protein, representing an infrequent mutation in patients with BBS 40 , because E234 is located at the top of the β-propeller, far away from the ARL6-interaction site (Fig. 5a) . BBS1N E234K was efficiently pulled down by GST-tagged HsARL6 Q73L and HsARL6 Q73L ∆N, and it bound untagged HsARL6 Q73L ∆N with a K d of 0.35 µM in ITC experiments, which is similar to that of wild-type BBS1N (Fig. 5b,c and Supplementary Fig. 6 ). These results demonstrated that up to 30% of all BBS mutations in patients could result in failure of ARL6-mediated recruitment of BBSomes to membranes, which in turn would probably prevent the proper ciliary trafficking of several membrane proteins.
DISCUSSION
There are clear similarities in sequence and domain composition of subunits from membrane coat complexes (COPI, COPII and clathrin-AP-1) and subunits from ciliary trafficking complexes (IFT and BBSome complexes), thus suggesting a common evolutionary origin 31, 41, 42 . Another commonality is the recruitment to membranes by Arf and Arf-like proteins, because COPI, AP-1 and GGA1 GAT are recruited by Arf1, and COPII is recruited by Sar1 (refs. 36, [43] [44] [45] . Whereas these complexes bind switch 1, switch 2 and the interswitch region (β-strands 2 and 3) of Arf1 and Sar1 mainly via α-helical structural elements, the recruitment of BBS1 by ARL6 is quite different (Fig. 6) . The β-propeller of BBS1 binds switch 2, α-helix 3 and residues from the loop preceding helix α1 of ARL6, to position the β-propeller on the opposite side of ARL6 (Fig. 6) . The recruitment mode of BBSomes by ARL6 is thus different from that found in other coating complexes, and it will be very interesting to see how the additional BBSome subunits related to COP and clathrin-AP-1 subunits contribute to coat formation and recognition of membrane proteins for ciliary transport.
METhODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METhODS
Protein purification and crystallization. Untagged or C-terminally histidinetagged CrBBS1N (residues 1-425) and HsBBS1N (residues 1-417) were cloned into pFL vectors, and the proteins were recombinantly expressed in High Five insect cells (Invitrogen). Full-length or ∆N (lacking residues 1-15) CrArl6 and HsArl6 were cloned into pET vectors with cleavable N-terminal histidine tags and were recombinantly overexpressed in E. coli BL21 (DE3). Proteins were purified by Ni-NTA affinity chromatography after lysis of cells in buffer A (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10% glycerol, 10 mM imidazole and 5 mM MgCl 2 ). After elution with 10-500 mM imidazole, overnight dialysis and histidine-tag cleavage by TEV protease, the proteins were passed back onto a Ni-NTA column, and the flow through was further purified by anion-exchange chromatography on a MonoQ column. As a last purification step, proteins were subjected to size-exclusion chromatography on a Superdex 75 column in buffer B containing 10 mM HEPES, pH 7.5, 150 mM NaCl, and 1 mM MgCl 2 . CrARL6∆N and CrBBS1N were cloned as a bicistronic construct for coexpression in High Five cells, and the CrARL6∆N-GTP-CrBBS1N complex was purified as described above.
Crystallization experiments were done by sitting-drop vapor-diffusion methods at 18 °C. CrArl6∆N that copurified with GTP was concentrated to 75 mg/ml, and crystals were obtained by mixture of the proteins with an equal volume of precipitant containing 30% (v/v) pentaerythritol ethoxylate, 50 mM Bis-Tris, pH 6.5, and 50 mM ammonium sulfate. To obtain GDP-bound CrArl6∆N, purified CrArl6∆N-GTP was incubated with buffer B containing 5 mM EDTA and no MgCl 2 for 3 h at 20 °C. This was followed by SEC in buffer B without MgCl 2 . The eluted nucleotide-free protein was mixed with 1 mM GDP in buffer B, subjected again to SEC, concentrated to 15 mg/ml and crystallized by mixture with equal volumes of precipitant containing 12% PEG 3350, 0.1 M HEPES, pH 7.5, 5 mM CdCl 2 , 5 mM MgCl 2 , 5 mM NiCl 2 and 5 mM CoCl 2 . The CrARL6-GTP-CrBBS1N complex was crystallized by mixture of the protein complex at 10 mg/ml with equal volumes of precipitant containing 29% PEG 400 and 0.1 M Tris, pH 8.0. Before flash cooling, crystals were cryoprotected by soaking in mother liquor supplemented with 25% glycerol (ARL6 crystals) or with the PEG 400 concentration increased to 35% (CrARL6-GTP-CrBBS1N crystals).
X-ray diffraction data collection and structure determination. X-ray diffraction data were acquired at the Swiss Light Source (SLS, Villigen, Switzerland) at beamlines PXII and PXIII. All diffraction data were collected at cryogenic temperatures (100 K) at wavelengths of 1.000 Å (CrARL6∆N-CrBBS1N and CrARL6∆N-GDP −CdCl 2 ), 1.0322 Å (CrARL6∆N-GTP), 1.0075 Å (CrARL6∆N-CrBBS1N-Hg) or 0.9497 Å (CrARL6∆N-CrBBS1N-Pb) . The data were indexed with the XDS package 46 before being scaled with Aimless in the CCP4 package 47, 48 . The structure of CrARL6-GTP was determined at 2.2-Å resolution by molecular replacement (MR) with the human ARL6 structure (PDB 2H57) as a search model in Phaser 49 as implemented in the PHENIX package 50 . Two molecules of CrARL6 were found in the asymmetric unit, and the structure was completed by iterative cycles of model building in Coot 51 and refinement in PHENIX. The CrARL6-GDP structure was determined at 1.4-Å resolution by single anomalous dispersion on cadmium-derivatized crystals. This was followed by autobuilding in PHENIX. For the CrARL6∆N-GTP-CrBBS1N complex structure, crystals were soaked in mother liquor complemented with 1.3 mM of the mercury compound EMP for 2 h. Crystals were then back-soaked in a cryosolution without EMP and flash cooled as described above. Anomalous data were recorded at the mercury peak wavelength of 1.0075 Å, which gave diffraction to 3.1 Å and anomalous signal to 4.4 Å. For structure determination, MR with CrARL6-GTP by Phaser located four molecules in the asymmetric unit. This MR solution was then used in an MR-SAD procedure as implemented in Phaser to find 35 mercury sites and to produce a high-quality electron density map ( Supplementary  Fig. 2f ) into which the CrBBS1N molecules were modeled. The four copies of CrARL6-GTP-CrBBS1N are very similar, and the structure was refined in PHENIX with four-fold NCS restraints. In addition to the mercury-derivatized CrARL6-GTP-CrBBS1N complex, structures were refined with native data to 3.45-Å resolution and with a lead-derivatized crystal that diffracted to 3.35-Å resolution. The CrARL6-GTP-CrBBS1N lead-derivatized crystals gave only a weak anomalous signal that did not extend beyond 7-Å resolution because of low-occupancy lead sites, and this data set can thus be considered as near native.
